<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Tal-Singer, Ruth</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Collaborations Aim to Speed Drug Development in COPD</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-15</style></pages><abstract><style  face="normal" font="default" size="100%">Drug discovery and development is a complex and expensive process. Clinical trials are major investments for industry and for academic researchers but also for patients, many of whom could undergo repeated clinical, radiographic, and laboratory assessments without the promise of therapeutic benefit.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>